FPR1 signaling aberrantly regulates S100A8/A9 production by CD14+FCN1hi macrophages and aggravates pulmonary pathology in severe COVID-19
Open Access
- 14 October 2024
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-14
Abstract
Excessive alarmins S100A8/A9 escalate the inflammation and even exacerbate immune-driven thrombosis and multi-organ damage. However, the regulatory mechanisms of S100A8/A9 expression in infectious diseases remain unclear. In this study, high-dimensional transcriptomic data analyses revealed a high proportion of CD14+FCN1hi macrophages within the pulmonary niche post-severe SARS-CoV-2 infection. By constructing the S100-coexpression gene list and supervised module scoring, we found that CD14+FCN1hi macrophages presented the highest scores of alarmin S100, and possibly served as the trigger and amplifier of inflammation in severe COVID-19. These CD14+FCN1hi cells lacked the positive regulatory activity of transcription factor PPARγ, and lost their differentiation ability towards mature macrophages. Ex vivo experiments further validated that the epithelial cells with high ORF-3a expression promoted the expression and secretion of S100A8/A9 through ANXA1/SAA1-FPR1 signaling. S100A8/A9 heterodimers, as well as the co-localization of S100A8/A9 with microtubules, were both diminished by the FPR1 inhibitor. Phospho-kinase protein array indicated that STAT3 promoted transcription, and PLC-γ and ERK1/2 pathways were involved in the hetero-dimerization and unconventional secretion of S100A8/A9. Our study highlights the pivotal role of FPR1 signaling in the excessive production of S100A8/A9 and provides a promising target for the prevention and control of severe COVID-19 and post-acute COVID-19 sequelae.Keywords
Funding Information
- Department of Science and Technology, Hubei Provincial People's Government (2022EHB035)
- Hubei Provincial Department of Education (1180011)
This publication has 48 references indexed in Scilit:
- Epigenetic memory of coronavirus infection in innate immune cells and their progenitorsCell, 2023
- Circulating Calprotectin (cCLP) in autoimmune diseasesAutoimmunity Reviews, 2023
- Alarmins in autoimmune diseasesAutoimmunity Reviews, 2022
- Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patientsEBioMedicine, 2022
- Multiple early factors anticipate post-acute COVID-19 sequelaeCell, 2022
- SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosisCell, 2021
- Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19Cell Host & Microbe, 2021
- The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Cell, 2020
- Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived CellsCell, 2019